Lattice Medical
PrivateLast Round
Grant
Jul 8, 2026
Est. Valuation
$333.42M
Total Funding Raised
$70.39M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lattice Medical operates in Healthcare & Life Sciences and is based in Loos. Its latest recorded funding round was a Grant round in July 2026.
Lattice Medical is a medtech company that develops and manufactures implantable medical devices for autologous soft tissue reconstruction using 3D printing technology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, 3D Printing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lattice Medical Comparables
Compare Lattice Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BellaSeno | 90% | |
| Healshape | 89% | |
| Tensive | 88% |
For institutional investors. Book with your work email.
Lattice Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 8, 2026 | ||||
| Series B | Oct 23, 2025 | ||||
| Grant | Sep 26, 2024 | ||||
| Grant | Jan 17, 2024 | ||||
| Series A | Jan 17, 2022 | ||||
Seed | Oct 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lattice Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series A |
| Blast.club | Series B |
| Secrétariat Général pour l'Investissement | Grant |
| SPRIM Global Investments | Series B |
| Finorpa | Seed, Series B, Series A |
| Siparex Group | Seed, Series B, Series A |
| France 2030 | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 8, 2026
$2.3M grant round from France 2030
- Jan 25, 2026
Grew 28% QoQ from 29 to 37 employees.
For institutional investors. Book with your work email.
Lattice Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lattice Medical's valuation, stock price, and market status.
Is Lattice Medical a public or private company?
Lattice Medical is a private company.
What is the current stock price of Lattice Medical?
Lattice Medical is a private company, so its shares have no public market price. Caplight tracks Lattice Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lattice Medical worth (valuation)?
Lattice Medical's valuation is estimated at $333.4M based on funding round data.
Can I buy Lattice Medical stock?
Lattice Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lattice Medical's last funding round?
Lattice Medical's most recent funding round was Grant on July 8, 2026.
Who are the main investors in Lattice Medical?
Key investors in Lattice Medical include Finorpa, Siparex Group, Finovam Gestion, WiSeed, Bpifrance.
Will Lattice Medical IPO soon?
No public IPO plans have been announced for Lattice Medical.
How can I track Lattice Medical secondary market activity?
Caplight tracks bids, offers, and trades in Lattice Medical's shares on secondary markets.